MedTrace Logo

Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

NCT04447534 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 191

Last updated 2022-04-01

No results posted yet for this study

Summary

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.

Conditions

Interventions

DRUG

Chloroquine or hydroxychloroquine

Chloroquine or hydroxychloroquine

DRUG

zinc

Zinc tablets

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • sherief Abd-Elsalam, Ass. Prof. · ass. Prof. Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-23
Primary Completion
2020-07-15
Completion
2020-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04447534 on ClinicalTrials.gov